Thomas Cahill

PRME

Thomas Cahill serves as Director at Prime Medicine, Inc. (PRME). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$6.80M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$6.80M

Companies Traded

PRME

Active Period

Oct 2022

1 total trades

Most Recent

Buy PRME

Oct 26, 2022 · $6.80M

Thomas Cahill's Insider Trading at Prime Medicine, Inc. (PRME)

Buys

1 · $6.80M

Sells

0 · $0.00

Total Shares Bought

400,000

Total Shares Sold

PRME Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 26, 2022	Buy	400,000	$17.00	$6.80M	5,305,679

Related Insiders

NELSEN ROBERT

Director

PRMEBuy · Aug 1, 2025

David R. Liu

10% Owner

PRMEBuy · Jun 30, 2025

LEE ANN L.

Chief Technical Officer

PRMEBuy · May 21, 2025

Allan Reine

Chief Executive Officer

PRMEBuy · May 21, 2025

Richard Brudnick

Chief Business Officer

PRMEBuy · May 20, 2025

Explore More Insider Trading Data

PRME Insider Trading Activity

View all insider trades at Prime Medicine, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity